» Articles » PMID: 21030178

Use of Dynamic Contrast-enhanced MRI to Measure Subtle Blood-brain Barrier Abnormalities

Overview
Publisher Elsevier
Specialty Radiology
Date 2010 Oct 30
PMID 21030178
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

There is growing interest in investigating the role of subtle changes in blood-brain barrier (BBB) function in common neurological disorders and the possible use of imaging techniques to assess these abnormalities. Some studies have used dynamic contrast-enhanced MR imaging (DCE-MRI) and these have demonstrated much smaller signal changes than obtained from more traditional applications of the technique, such as in intracranial tumors and multiple sclerosis. In this work, preliminary results are presented from a DCE-MRI study of patients with mild stroke classified according to the extent of visible underlying white matter abnormalities. These data are used to estimate typical signal enhancement profiles in different tissue types and by degrees of white matter abnormality. The effect of scanner noise, drift and different intrinsic tissue properties on signal enhancement data is also investigated and the likely implications for interpreting the enhancement profiles are discussed. No significant differences in average signal enhancement or contrast agent concentration were observed between patients with different degrees of white matter abnormality, although there was a trend towards greater signal enhancement with more abnormal white matter. Furthermore, the results suggest that many of the factors considered introduce uncertainty of a similar magnitude to expected effect sizes, making it unclear whether differences in signal enhancement are truly reflective of an underlying BBB abnormality or due to an unrelated effect. As the ultimate aim is to achieve a reliable quantification of BBB function in subtle disorders, this study highlights the factors which may influence signal enhancement and suggests that further work is required to address the challenging problems of quantifying contrast agent concentration in healthy and diseased living human tissue and of establishing a suitable model to enable quantification of relevant physiological parameters. Meanwhile, it is essential that future studies use an appropriate control group to minimize these influences.

Citing Articles

MRI detects blood-brain barrier alterations in a rat model of Alzheimer's disease and lung infection.

Ohene Y, Morrey W, Powell E, Smethers K, Luka N, South K Npj Imaging. 2025; 3(1):8.

PMID: 40051735 PMC: 11879872. DOI: 10.1038/s44303-025-00071-5.


Noninvasive blood-brain barrier integrity mapping in patients with high-grade glioma and metastasis by multi-echo time-encoded arterial spin labeling.

Hoffmann G, Preibisch C, Gunther M, Mahroo A, van Osch M, Vaclavu L Magn Reson Med. 2025; 93(5):2086-2098.

PMID: 39777739 PMC: 11893035. DOI: 10.1002/mrm.30415.


Diagnostic Utility of Integration of Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast MR Perfusion Employing Split Bolus Technique in Differentiating High-Grade Glioma.

Malik V, Kesavadas C, Thomas B, N D, K K Indian J Radiol Imaging. 2024; 34(3):382-389.

PMID: 38912247 PMC: 11188723. DOI: 10.1055/s-0043-1777742.


Anti-inflammatory interleukin 1 receptor antagonist concentration in plasma correlates with blood-brain barrier integrity in the primary lesion area in traumatic brain injury patients.

To X, Donnelly P, Maclachlan L, Mahady K, Apellaniz E, Cumming P Brain Behav Immun Health. 2023; 31:100653.

PMID: 37415924 PMC: 10320227. DOI: 10.1016/j.bbih.2023.100653.


Application of diffusion weighted multiple boli ASL to a murine model of human African trypanosomiasis.

Paterson S, Vallatos A, Rodgers J, Holmes W Sci Rep. 2023; 13(1):8684.

PMID: 37248398 PMC: 10227057. DOI: 10.1038/s41598-023-34665-z.


References
1.
Andersen C, Jensen F . Differences in blood-tumour-barrier leakage of human intracranial tumours: quantitative monitoring of vasogenic oedema and its response to glucocorticoid treatment. Acta Neurochir (Wien). 1998; 140(9):919-24. DOI: 10.1007/s007010050194. View

2.
Bronge L, Wahlund L . White matter lesions in dementia: an MRI study on blood-brain barrier dysfunction. Dement Geriatr Cogn Disord. 2000; 11(5):263-7. DOI: 10.1159/000017248. View

3.
Pickup S, Wood A, Kundel H . Gadodiamide T1 relaxivity in brain tissue in vivo is lower than in saline. Magn Reson Med. 2005; 53(1):35-40. DOI: 10.1002/mrm.20336. View

4.
Soon D, Tozer D, Altmann D, Tofts P, Miller D . Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler. 2007; 13(7):884-94. DOI: 10.1177/1352458507076970. View

5.
Stanisz G, Henkelman R . Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med. 2000; 44(5):665-7. DOI: 10.1002/1522-2594(200011)44:5<665::aid-mrm1>3.0.co;2-m. View